MD Anderson Research Highlights for June 29, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and ...
Tag: Anderson
MD Anderson and Turning Point Therapeutics announce strategic alliance to advance precision cancer therapies
HOUSTON and SAN DIEGO ― The University of Texas MD Anderson Cancer Center and Turning Point Therapeutics, Inc., today announced ...
MD Anderson, Invectys and CTMC announce strategic collaboration for CAR T cell therapy development
HOUSTON ― The University of Texas MD Anderson Cancer Center, Invectys, Inc. and the Cell Therapy Manufacturing Center (CTMC), a ...
MD Anderson research highlights for June 15, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and ...
MD Anderson and Resilience launch joint venture to accelerate development and manufacturing of innovative cell therapies for cancer
HOUSTON and SAN DIEGO ― The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the ...
MD Anderson Research Highlights for June 1, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and ...
MD Anderson Research Highlights for May 18, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and ...
SynGAP Research Fund (SRF) announces $128,000 grant for stem cell gene therapy translational research to Dr. Joe Anderson of the University of California, Davis
Could a bone marrow transplant, including modified stem cells, provide a one-time treatment for SYNGAP1? Credit: Syngap Research Fund Could ...
MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers
HOUSTON ― The University of Texas MD Anderson Cancer Center was awarded more than $10 million in grants to support ...
MD Anderson research highlights for April 13, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in ...
MD Anderson launches James P. Allison Institute to usher in new era for immunotherapy
HOUSTON ― The University of Texas MD Anderson Cancer Center today launched the James P. Allison Institute, a visionary research and ...
MD Anderson research highlights: SGO 2022 Special Edition
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent studies in basic, ...
MD Anderson research highlights for March 9, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational ...
MD Anderson Research Highlights for February 23, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, ...
Center for Assurance Research & Engineering (CARE) announces the appointment of Tom Anderson as a senior fellow
The George Mason Center for Assurance Research & Engineering (CARE) today announced the appointment of Tom Anderson as a Senior ...
MD Anderson honors World Cancer Day, reinforces commitment to cancer care, prevention, research and education
HOUSTON ― The University of Texas MD Anderson Cancer Center celebrates World Cancer Day, Feb. 4, in honor of the global initiative to ...
MD Anderson Research Highlights for January 26, 2022
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, ...
MD Anderson and Yingli Pharma initiate strategic collaboration to advance development of multiple oncology programs
HOUSTON and SAN FRANCISCO ― The University of Texas MD Anderson Cancer Center and Yingli Pharma US, Inc. today announced ...
MD Anderson and Eisbach Bio announce strategic collaboration to develop medicines targeting epigenetic machinery in oncology
HOUSTON and MUNICH ― The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic ...
MD Anderson Research Highlights for January 12, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational ...
-
How to MRI your dragon: Illinois researchers develop first bearded dragon brain atlas
-
Immune molecules from a llama could provide protection against a vast array of SARS-like viruses including COVID-19, researchers say
-
Researchers perform non-line-of-sight ghost imaging with human vision
-
Unique blend of comics and humor is key to success of public awareness posters in Singapore, finds Singapore-US researchers
-
Human urine-derived stem cells have robust regenerative potential
-
Researchers develop word-score model capable of estimating hidden hearing loss